Guest
Signals accepts guest blog posts on topics relevant to stem cells and regenerative medicine, as well as submissions for its Right Turn Friday feature. The opinions, accuracy, completeness and validity of any statements made in guest posts are the responsibility of the author only and not the editor of Signals or CCRM, publisher of Signals. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with the author. To reach the publisher, email info(at)CCRM.ca
Posts by: Guest
Five regenerative medicine workshops to attend this summer
Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for […]
Funding the future: Highlights from Bloom Burton & Co.’s Healthcare Investor Conference
Samantha Yammine is a PhD Candidate in Dr. Derek van der Kooy’s lab at the University of Toronto studying how stem cells develop and maintain the brain. Samantha is passionate about science advocacy, policy, and education, and is an avid science communicator. You can find her sharing science straight from the lab on Instagram (@science.sam), […]
Improving ultrasound imaging may have applications in regenerative medicine
Andy Bell, a writer working with Toronto3dprinting, loves to write about different topics related to technological gadgets and gears. 3D printing is his current interest. Though ultrasound technology is commonly associated with the imaging of fetuses in the womb, its applications are much more than just imaging. The acoustic waves generated by ultrasound devices can […]
Cells…in a box
Heather Blumenthal has been writing about health and health research for more than 20 years and never loses her fascination with the advances Canadian researchers are making. You can reach her at hblumenthal@sympatico.ca It’s like magic – insert a cancer patient’s blood cells in one end and out the other end come T-cells adapted for […]
Peter Zandstra and CCRM: Making cell therapies a commercial reality
Dr. Rohin Iyer is currently a Development Manager at GE Healthcare / CCRM. He did his PhD in Biomedical Engineering at the University of Toronto, and has been working in the field of stem cells and tissue engineering for over 12 years. He is an avid tweeter (follow @DrRohinIyer) on cell therapies and regenerative medicine. […]